Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs

Author： O'Hagan D.   Goldbeck C.   Ugozzoli M.   Ott G.   Burke R.L.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.17, Iss.18, 1999-05, pp. : 2229-2236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes

By Gebhard J.R.J.R.   Zhu J.   Cao X.   Minnick J.   Araneo A.B.A.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1837-1846

Elsevier

Access to resources Recommend Favorite

Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus

By Gallichan W.S.   Rosenthal K.L.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1589-1595

Elsevier

Access to resources Recommend Favorite

The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs

By McClements W.L.   Armstrong M.E.   Keys R.D.   Liu M.A.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 857-860

Elsevier

Access to resources Recommend Favorite

Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection

By Bernstein D.I.   Tepe E.R.   Mester J.C.   Arnold R.L.   Stanberry L.R.   Higgins T.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1964-1969

Elsevier

Access to resources Recommend Favorite

Immunity induced by DNA immunization with herpes simplex virus type 2 glycoproteins B and C

By Mester J.C.   Twomey T.A.   Tepe E.T.   Bernstein D.I.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 875-883

Elsevier

Access to resources Recommend Favorite